Regional brain expression of several Alzheimer-risk genes, including APOE, CD33, and SORL1, showed a strong correlation with brain metabolism, particularly in regions of the brain that are affected earliest and most severely in Alzheimer’s disease (Ye et al., 2022). The gene discussed is CD33; the disease is Alzheimer disease.